The presence and density of TILs have significant prognostic implications in breast cancer, particularly in specific subtypes like triple-negative breast cancer (TNBC) and HER2+ breast cancer, due to their higher immunogenicity compared to hormone receptor-positive (HR+) breast cancer. This evidence concerns the gene ERBB2 and breast carcinoma.